Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$316K Sell
159
-17
-10% -$27.1K 0.01% 606
2026
Q1
$232K Buy
176
+55
+45% +$75.4K 0.01% 680
2025
Q4
$129K Buy
121
+4
+3% +$4.17K ﹤0.01% 807
2025
Q3
$113K Buy
117
+16
+16% +$12.6K ﹤0.01% 806
2025
Q2
$81K Sell
101
-2
-2% -$1.44K ﹤0.01% 790
2025
Q1
$68K Buy
+103
New +$74.9K ﹤0.01% 796
2022
Q3
Sell
-59
Closed -$28K 498
2022
Q2
$28K Buy
+59
New +$32.9K ﹤0.01% 778

Other funds holding ASML

CX Institutional's ASML Position: Q2 2026 in Review

CX Institutional reduced its ASML (ASML) stake by 9.7% in Q2 2026, selling an estimated $27.1K and leaving 159 shares worth $316K. The position accounts for 0.01% of the portfolio, ranked #606.

CX Institutional first reported a position in ASML in Q2 2022 and has held it in 7 quarters since. 2,496 funds tracked by Wall St. Rank hold ASML as of Q2 2026.

  • CX Institutional held 159 shares of ASML worth $316K as of Q2 2026.
  • CX Institutional sold 17 ASML shares in Q2 2026, an estimated $27.1K.
  • ASML made up 0.01% of CX Institutional's portfolio in Q2 2026, its #606 holding.
  • CX Institutional first reported a position in ASML in Q2 2022 and has held it in 7 quarters since.
  • 2,496 funds tracked by Wall St. Rank held ASML as of Q2 2026.

Based on CX Institutional's 13F filing for Q2 2026, filed 2 Jul 2026.